What we do Epigral Limited manufactures and sells chlor-alkali products, derivatives, and specialty chemicals including caustic soda, CPVC resin, and epichlorohydrin, serving diverse industries. |
Founded in 2,007 |
Market share Among the top chlor-alkali and specialty chemical producers in India; largest CPVC and epichlorohydrin capacities nationally. |
Problem solved Provides essential industrial chemicals enabling sectors like pharmaceuticals, agrochemicals, textiles, and construction to substitute imports and ensure reliable local supply. |
Top clients or who we serve Serves B2B clients across pharmaceuticals, agrochemicals, textiles, consumer goods, and manufacturing sectors in India and select international markets. |
Key management Chairman & Managing Director Maulik Patel, Executive Director Kaushal Soparkar, supported by experienced independent directors with industry expertise. |
Our journey and innovations From 2007 inception, expanded chlor-alkali capacity over 400 KTPA; commissioned India's first epichlorohydrin and world's largest CPVC resin plants, integrating renewable power and R&D. |
Where we operate Manufacturing in Dahej, Gujarat; sales primarily India with some international exports. |
Top products or what we offer Caustic soda, caustic potash, CPVC resin and compound, epichlorohydrin, chloromethanes, hydrogen peroxide, and chlorotoluenes. |
Top brands Epigral CPVC resin (India's largest capacity), Epichlorohydrin (sole Indian producer), Chlorotoluenes value chain (first commissioned in India). |
Raw materials needed Chlorine, hydrogen, salt, and various chemicals for electrolysis and chlorination. |
Raw materials supplier Sourced locally and integrated internally via captive power and chemical plants. |
Recurring vs cyclical contribution Revenues mainly recurring from chemical manufacturing supplying diversified industries with moderate cyclicality. |
Our industry position 3rd largest caustic potash producer, 4th largest caustic soda in India, top 6 in derivatives and specialty chemicals. |
Financial highlights FY25 revenue ₹2,565 Cr, PAT ₹357 Cr; steady growth with 5-year revenue CAGR ~33%, EBITDA margin ~28%. |
Geographical revenue split FY25 revenue mostly from India (~93%), with exports accounting for ~7%. |
Order book - |
Whats driving growth Capacity expansions, integration across chemical value chains, rising domestic specialty chemical demand, and sustainability initiatives. |
Our future plans Expand CPVC resin to 150,000 TPA, double epichlorohydrin capacity, commission wind-solar hybrid power, and develop new specialty chemicals. |
Our green promise Focus on sustainable bio-based chemicals, renewable hybrid power plant, ESG framework, and environmental compliance. |
Our people and values 1,100+ employees fostering culture of agility, care, collaboration, and innovation. |
Key challenges ahead Raw material price volatility, regulatory compliance, and maintaining margins amid demand fluctuations. |
Interesting facts First in India to produce bio-based epichlorohydrin and commission chlorotoluenes value chain facility. |
Risks and strategy Mitigating raw material cost risks via integration and long-term contracts; strategic capex to enhance specialty chemical portfolio. |
